MAPK14 and hepatocellular carcinoma: Given the functional recovery obtained with selected specific p38 inhibitors, the knowledge generated in this study altogether has relevant potential for novel and more effective strategies of NK cell reconstitution, thus able to improve immunotherapy for HCC patients.